Biosynex: takeover bid extended for Chembio Diagnostics
2023, subject to further extension.
The tender offer was to expire on March 28, 2023.
All other terms and conditions of the tender offer remain unchanged, says Biosynex.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction